Weight-Loss drug trial targets severely obese kids
NCT ID NCT07590219
First seen May 16, 2026 · Last updated Jun 16, 2026 · Updated 8 times
Summary
This study tests whether the drug liraglutide, combined with healthy lifestyle changes, helps children aged 6 to 12 with severe obesity lose weight and improve heart health. Thirty children will either receive the drug plus lifestyle support or lifestyle support alone for 6 months. The goal is to see if the drug can safely reduce body mass index (BMI) and improve heart function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Childrens Institute - University of Sao Paulo
São Paulo, São Paulo, 05403-000, Brazil
Conditions
Explore the condition pages connected to this study.